The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC ...

If the FDA and CDC sit on their hands, next season the flu shot will be a lot more expensive, if you can find it at all. That ...

Martin Makary, an author and surgeon at Johns Hopkins University, has appeared frequently on Fox News to talk about health ...

More states are loosening vaccine mandates, scaling back vaccine promotion efforts and taking other steps likely to lower ...

Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.

If passed, anyone who provides or administers a gene-based vaccine to another person would face a penalty of $500 per ...

Pfizer reacts to Donald Trump’s tariff threats on big pharma, another regulatory meeting is canceled under RFK Jr., AbbVie ...

Health experts are raising concerns after US Health Secretary Robert F Kennedy Jr suggested vitamin A and nutrition as measles treatments, without explicitly endorsing vaccination. With a major ...

COVID is still circulating in hospitals, according to Dr. Ken Lyn-Kew of National Jewish, but fewer are getting severely sick ...

From a historic vaccine approval to a $50bn investment reshaping US drug manufacturing, February brought major pharma news to ...

Ocugen (NASDAQ: OCGN) Q4 2024 Earnings Call Mar 05, 2025, 8:30 a.m. ET ...